At the news
? BULLISHIMPACT 5/10 CLUSTER filed May 27, 2026 at 15:20 ET
Two directors at Outlook Therapeutics made open-market purchases totaling ~$179K on May 26, 2026, just 13 days after the company filed an at-the-market (ATM) offering agreement for up to $100M in common stock. Director Kurt J. Hilzinger bought 400,000 shares ($177K) and Director Randy H. Thurman bought 5,000 shares ($2K). The purchases represent ~0.37% of the company's $48M market cap, a notable insider vote of confidence given the massive dilution overhang from the recently disclosed ATM facility.
- Director Kurt J. Hilzinger purchased 400,000 shares at ~$0.44/share for $177K on 2026-05-26
- Director Randy H. Thurman purchased 5,000 shares at ~$0.43/share for $2K on 2026-05-26
- Total open-market insider purchases: ~$179K, representing ~0.37% of $48M market cap
- Purchases occurred 13 days after filing an ATM offering agreement for up to $100M in common stock (filed 2026-05-13)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access